Published in Oncogene on September 02, 2013
Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol (2014) 1.57
The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med (2015) 1.44
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell (2017) 1.41
What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer Tissue. PLoS One (2016) 1.40
Stromal reengineering to treat pancreas cancer. Carcinogenesis (2014) 1.00
CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer. Nature (2015) 0.99
Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. Oncotarget (2015) 0.96
IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma. Cancer Discov (2016) 0.96
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies. Oncogene (2015) 0.92
Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer. Biomed Res Int (2014) 0.90
Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. Mol Pharm (2014) 0.87
Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol (2017) 0.86
Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World J Gastroenterol (2016) 0.85
Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology (2016) 0.84
Molecular pathways: myeloid complicity in cancer. Clin Cancer Res (2014) 0.84
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. Cancer Res (2016) 0.83
Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages. Cancers (Basel) (2014) 0.82
Lurbinectedin induces depletion of tumor-associated macrophages, an essential component of its in vivo synergism with gemcitabine, in pancreatic adenocarcinoma mouse models. Dis Model Mech (2016) 0.82
Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling. Cell Death Dis (2015) 0.80
Immunologic and Metabolic Features of Pancreatic Ductal Adenocarcinoma Define Prognostic Subtypes of Disease. Clin Cancer Res (2016) 0.79
Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Mol Pharm (2016) 0.77
Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J Biol Chem (2014) 0.77
Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Transl Oncol (2015) 0.77
What are the macrophages and stellate cells doing in pancreatic adenocarcinoma? Front Physiol (2015) 0.76
Afatinib, a lung cancer inhibitor of ErbB family. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer. Trends Mol Med (2017) 0.75
Macrophages as Key Drivers of Cancer Progression and Metastasis. Mediators Inflamm (2017) 0.75
Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma. PLoS One (2017) 0.75
Cell-cycle-controlled radiation therapy was effective for treating a murine malignant melanoma cell line in vitro and in vivo. Sci Rep (2016) 0.75
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer. World J Gastrointest Oncol (2017) 0.75
Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice. Oncoimmunology (2016) 0.75
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer. Oncotarget (2016) 0.75
Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model. PLoS One (2017) 0.75
Microfluidic device for primary tumor spheroid isolation. Exp Hematol Oncol (2017) 0.75